Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

CBL0137

CBL0137, a curaxin compound, is a histone chaperone facilitates chromatin transcription (FACT) inhibitor. CBL0137 downregulates NF-κB and activates p53. CBL0137 restores both histone H3 acetylation and trimethylation. CBL0137 is an anticancer agent. CBL0137 induces cancer cell apoptosis[1].

Product Specifications

CAS Number

1197996-80-7

Product Name Alternative

Curaxin 137; CBL-C137

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Histone Acetyltransferase; MDM-2/p53; NF-κB

Type

Reference compound

Related Pathways

Apoptosis; Epigenetics; NF-κB

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/CBL-0137.html

Concentration

10mM

Purity

99.73

Solubility

DMSO : 11.11 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

CC(NCCN1C2=C(C3=C1C=CC(C(C)=O)=C3)C=C(C(C)=O)C=C2)C

Molecular Formula

C21H24N2O2

Molecular Weight

336.43

Precautions

H302, H315, H319, H335

References & Citations

[1]Barone TA, et al. Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma. Neuro Oncol. 2017 Feb 1;19 (2) :186-196. h|[2]Burkhart C, et al. Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer. Oncotarget. 2014 Nov 30;5 (22) :11038-53.|[3]Ehteda A, et al. Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG. Cell Rep. 2021 Apr 13;35 (2) :108994.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

Phase 2

Citation 01

Cell Death Dis. 2024 Oct 27;15 (10) :779.|Eur J Med Chem. 2024 Apr 15:270:116377.|J Neuroinflammation. 2025 Oct 27;22 (1) :243.|Nano Today. 2025 Oct.|Adv Mater. 2024 Jul;36 (29) :e2313991.|Cancer Res. 2021 Jun 1;81 (11) :3105-3120.|Cell Death Dis. 2020 Dec 2;11 (12) :1029.|Cell. 2024 Dec 26;187 (26) :7533-7550.e23.|Mol Med Rep. 2024 Nov;30 (5) :209.|Oncogene. 2023 Jan;42 (1) :11-25.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Myo5a ORF Vector (Mouse) (pORF)
31294014 1.0 µg DNA

Myo5a ORF Vector (Mouse) (pORF)

Sign In for Pricing
View Details
Beaker, 5000mL, PP
600819 2/CS

Beaker, 5000mL, PP

Sign In for Pricing
View Details
Rabbit Anti Human Antithrombin III Polyclonal Fractionated HRP Labeled 1mg
IRBAHUATIIIGFHRP1MG 1 mg

Rabbit Anti Human Antithrombin III Polyclonal Fractionated HRP Labeled 1mg

Sign In for Pricing
View Details
Human Proepiregulin (EREG) ELISA Kit
abx251338 96 Well

Human Proepiregulin (EREG) ELISA Kit

Sign In for Pricing
View Details
14-Hydroxyhexadecanoic acid
OR1063498-01 50 mg

14-Hydroxyhexadecanoic acid

Sign In for Pricing
View Details
14-Hydroxyhexadecanoic acid
OR1063498-02 100 mg

14-Hydroxyhexadecanoic acid

Sign In for Pricing
View Details